These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37056864)

  • 21. Clinical value and expression of Homer 1, homocysteine, S-adenosyl-l-homocysteine, fibroblast growth factors 23 in coronary heart disease.
    Zhang Z; Wang L; Zhan Y; Xie C; Xiang Y; Chen D; Wu Y
    BMC Cardiovasc Disord; 2022 May; 22(1):215. PubMed ID: 35546659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of hyaluronic acid and laminin in coronary heart disease patients complicated with myocardial infarction.
    Li X; Lu Y
    Am J Transl Res; 2021; 13(8):9032-9039. PubMed ID: 34540015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease?
    Bahceci M; Tuzcu A; Ogun C; Canoruc N; Iltimur K; Aslan C
    J Endocrinol Invest; 2005 Feb; 28(2):145-50. PubMed ID: 15887860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of serum IGF-1, AGEs and their receptors with the risk of colorectal cancer in patients with type 2 diabetes mellitus.
    Chen Z; Hong Q
    Front Oncol; 2023; 13():1125745. PubMed ID: 36890832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucagon-Like Peptide-1 Receptor Agonist Utilization in Type 2 Diabetes in Japan: A Retrospective Database Analysis (JDDM 57).
    Ishigaki Y; Strizek A; Aranishi T; Arai N; Imaoka T; Cai Z; Maegawa H
    Diabetes Ther; 2021 Jan; 12(1):345-361. PubMed ID: 33300091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin resistance, blood glucose and inflammatory cytokine levels are risk factors for cardiovascular events in diabetic patients complicated with coronary heart disease.
    Wang C; Li F; Guo J; Li C; Xu D; Wang B
    Exp Ther Med; 2018 Feb; 15(2):1515-1519. PubMed ID: 29434736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of GLP-1/GLP-1R on the Polarization of Macrophages in the Occurrence and Development of Atherosclerosis.
    Yang L; Chen L; Li D; Xu H; Chen J; Min X; He M; Wu T; Zhong J; Yang H; Chen J
    Mediators Inflamm; 2021; 2021():5568159. PubMed ID: 33854404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and Type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China.
    Yang T; Liu Y; Li L; Zheng Y; Wang Y; Su J; Yang R; Luo M; Yu C
    Cardiovasc Diabetol; 2022 Jun; 21(1):93. PubMed ID: 35659300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases.
    Cai HJ; Li ZX; Yang SM
    Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of Long Non-coding RNA LncRNA-FA2H-2 With Inflammatory Markers in the Peripheral Blood of Patients With Coronary Heart Disease.
    Guo F; Sha Y; Hu B; Li G
    Front Cardiovasc Med; 2021; 8():682959. PubMed ID: 34235188
    [No Abstract]   [Full Text] [Related]  

  • 31. Predictive value of bilirubin and serum γ-glutamyltranspeptidase levels in type-2 diabetes mellitus patients with acute coronary syndrome.
    Chen J; Zhang WC; Tang XQ; Yin RH; Wang T; Wei XY; Pan CJ
    World J Diabetes; 2024 Jan; 15(1):34-42. PubMed ID: 38313856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between serum Sestrin2 and the risk of coronary heart disease in patients with type 2 diabetes mellitus.
    Tian X; Gao Y; Zhong M; Kong M; Zhao L; Feng Z; Sun Q; He J; Liu X
    BMC Cardiovasc Disord; 2022 Jun; 22(1):281. PubMed ID: 35729499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of GLP-1 receptor agonist on insulin dosage and blood glucose control of patients with type 2 diabetes mellitus.
    Shen Y; Yang X; Han X; Xi W; Jiang L; Wang S; Zhong H; Gu Y
    Am J Transl Res; 2021; 13(10):11814-11823. PubMed ID: 34786110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [An analysis of relationship between the severity of coronary artery lesion and risk factors of cardiovascular events in Tianjin].
    Xiao JY; Zhang HN; Cao L; Cong HL
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Nov; 25(11):650-4. PubMed ID: 24225217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low glucagon-like peptide-1 (GLP-1) concentration in serum is indicative of mild cognitive impairment in type 2 diabetes patients.
    Wu P; Zhao Y; Zhuang X; Sun A; Zhang Y; Ni Y
    Clin Neurol Neurosurg; 2018 Nov; 174():203-206. PubMed ID: 30273843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression and prognostic value of ischemia modified albumin (IMA), red blood cell distribution width (RDW), and lipoprotein (LP) in patients with diabetes mellitus complicated with coronary heart disease.
    Xiang L; Zhang M; Wu H; Xie D
    Ann Palliat Med; 2021 Apr; 10(4):4463-4471. PubMed ID: 33894715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus.
    Hare KJ
    Dan Med Bull; 2010 Sep; 57(9):B4181. PubMed ID: 20816021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of serum PCSK9 in CHD patients with the severity of coronary arterial lesions.
    Wang S; Cheng ZY; Zhao ZN; Quan XQ; Wei Y; Xia DS; Li JQ; Hu JL
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1135-9. PubMed ID: 27049268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between insulin resistance, adiponectin and C-reactive protein and vascular endothelial injury in diabetic patients with coronary heart disease.
    Xu W; Tian M; Zhou Y
    Exp Ther Med; 2018 Sep; 16(3):2022-2026. PubMed ID: 30186434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of glucose-lowering rate on CKMB and myoglobin serum levels in type-2 diabetes patients with coronary heart disease.
    Sun Z; Wu W; Liu J; Ma N; Zheng Z; Li Q; Wang M; Miao J
    Hum Immunol; 2014 Dec; 75(12):1182-7. PubMed ID: 25454625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.